SMMT vs. VKTX

In the year-to-date period, SMMT achieves a 38.13% return, which is significantly higher than VKTX's -30.79% return. Over the past 10 years, SMMT has underperformed VKTX with an annualized return of 8.78%, while VKTX has yielded a comparatively higher 11.51% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SMMT Sharpe Ratio is 1.34, which is higher than the VKTX Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of SMMT and VKTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither SMMT nor VKTX has paid dividends to shareholders.

The maximum SMMT drawdown since its inception was -95.75%, which is greater than VKTX's maximum drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for SMMT and VKTX. For additional features, visit the drawdowns tool.

Summit Therapeutics Inc. (SMMT) has a higher volatility of 60.73% compared to Viking Therapeutics, Inc. (VKTX) at 24.97%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Viking Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.